🟢 MannKind is trading 7.6% up in pre-market with no clear catalyst identified

MannKind is trading at $4.09, up 7.60%, with no clear company-specific catalyst identified for the move.

• No clear company-specific announcement or fresh catalyst for October 5 was identified.
• The September 30 Delaware ruling was previously described as supportive of MannKind’s Tyvaso DPI royalties, but does not establish the cause of this pre-market move.
• Major U.S. indices are nearly flat in the supplied market context, so broad-market strength does not clearly explain the gain.